409 related articles for article (PubMed ID: 32035236)
1. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
2. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
[TBL] [Abstract][Full Text] [Related]
3. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
Renkoğlu P; Çelebier M; Arıca-Yegin B
Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
[TBL] [Abstract][Full Text] [Related]
4. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.
Serrano DR; Walsh D; O'Connell P; Mugheirbi NA; Worku ZA; Bolas-Fernandez F; Galiana C; Dea-Ayuela MA; Healy AM
Eur J Pharm Biopharm; 2018 Mar; 124():13-27. PubMed ID: 29196273
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
6. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
Drozd KV; Manin AN; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
[TBL] [Abstract][Full Text] [Related]
8. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
9. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
Zeng QZ; Ouyang J; Zhang S; Zhang L
Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
[TBL] [Abstract][Full Text] [Related]
11. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal.
Gajda M; Nartowski KP; Pluta J; Karolewicz B
Eur J Pharm Biopharm; 2018 Oct; 131():48-59. PubMed ID: 30205892
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Suspension Formulations of Theophylline Cocrystals With Artificial Sweeteners.
Aitipamula S; Wong ABH; Kanaujia P
J Pharm Sci; 2018 Feb; 107(2):604-611. PubMed ID: 28987500
[TBL] [Abstract][Full Text] [Related]
13. Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization.
Li S; Yu T; Tian Y; McCoy CP; Jones DS; Andrews GP
Mol Pharm; 2016 Sep; 13(9):3054-68. PubMed ID: 27314248
[TBL] [Abstract][Full Text] [Related]
14. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability.
Liu L; Zou D; Zhang Y; Zhang Q; Feng Y; Guo Y; Liu Y; Zhang X; Cheng G; Wang C; Zhang Y; Zhang L; Wu L; Chang L; Su X; Duan Y; Zhang Y; Liu M
Eur J Pharm Biopharm; 2020 Sep; 154():62-73. PubMed ID: 32645384
[TBL] [Abstract][Full Text] [Related]
16. Cocrystals of acyclovir with promising physicochemical properties.
Sarkar A; Rohani S
J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
[TBL] [Abstract][Full Text] [Related]
17. Cocrystallization of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicines.
Guo H; Liu S
Chem Pharm Bull (Tokyo); 2023; 71(5):326-333. PubMed ID: 37121683
[TBL] [Abstract][Full Text] [Related]
18. Cocrystals of Praziquantel with Phenolic Acids: Discovery, Characterization, and Evaluation.
Yang S; Liu Q; Ji W; An Q; Song J; Xing C; Yang D; Zhang L; Lu Y; Du G
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335384
[TBL] [Abstract][Full Text] [Related]
19. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
